Results 151 to 160 of about 509,198 (290)

Open‐source deep‐learning models for segmentation of normal structures for prostatic and gynecological high‐dose‐rate brachytherapy: Comparison of architectures

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Background The use of deep learning‐based auto‐contouring algorithms in various treatment planning services is increasingly common. There is a notable deficit of commercially or publicly available models trained on large or diverse datasets containing high‐dose‐rate (HDR) brachytherapy treatment scans, leading to poor performance on images ...
Andrew J. Krupien, Yasin Abdulkadir, Dishane C. Luximon, John Charters, Huiming Dong, Jonathan Pham, Dylan O'Connell, Jack Neylon, James M. Lamb   +8 more
wiley   +1 more source

PCH1: PAMIDRONATE FOR BREAST CANCER PATIENTS WITH SKELETAL METASTASES: A MARKOV TREE-BASED COST-UTILITY ANALYSIS

, 2000
NL Liberato, Marco Marchetti, A Tamburlini, Giovanni Barosi   +3 more
openalex   +1 more source

Novel CT radiomics models for the postoperative prediction of early recurrence of resectable pancreatic adenocarcinoma: A single‐center retrospective study in China

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose To assess the predictive capability of CT radiomics features for early recurrence (ER) of pancreatic ductal adenocarcinoma (PDAC). Methods Postoperative PDAC patients were retrospectively selected, all of whom had undergone preoperative CT imaging and surgery. Both patients with resectable or borderline‐resectable pancreatic cancer met
Xinze Du, Yongsu Ma, Kexin Wang, Xiejian Zhong, Jianxin Wang, Xiaodong Tian, Xiaoying Wang, Yinmo Yang   +7 more
wiley   +1 more source

Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure

International Journal of Integrated Care, 2013
Praveen Thokala, Baalbaki Hassan, Pandor Abdullah, John W. Stevens, Brennan Alan   +4 more
doaj   +3 more sources

PCN8: COST-UTILITY ANALYSIS OF SEVERAL SECOND-LINE CHEMOTHERAPY SCHEMES FOR PATIENTS WITH METASTATIC BREAST CANCER

, 2000
CA Uyl‐de Groot, N Li, Michel van Agthoven, PH Willemse   +3 more
openalex   +1 more source

Clinical validation of myOSLchip: A beryllium oxide optically stimulated luminescent dosimeter (OSLD) system in radiotherapy dosimetry

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract In radiation oncology, inter‐fractional dosimetry using optically stimulated luminescent detectors (OSLDs) ensures accurate plan delivery and patient safety. RadPro International GmbH's myOLSchip system, featuring a beryllium oxide (BeO) OSL dosimeter, reader, and eraser, was characterized and calibrated with a Varian Truebeam for in‐vivo ...
Heath Davis, Jeffrey V. Siebers, Krishni Wijesooriya, Matt Mistro   +3 more
wiley   +1 more source

PAO9: IS RESIDRONATE MORE COST-EFFECTIVE THAN ETIDRONATE FOR FRACTURE PREVENTION? A COST-UTILITY ANALYSIS

, 2000
C Iglesias, David Torgerson
openalex   +1 more source

Screening for Hepatitis C in injecting drug users: a cost utility analysis [PDF]

, 2004
Ken Stein, Kim Dalziel, Andrew Walker, Becky Jenkins, A Round, Pamela Royle   +5 more
openalex   +1 more source

Using deep learning generated CBCT contours for online dose assessment of prostate SABR treatments

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Prostate Stereotactic Ablative Body Radiotherapy (SABR) is an ultra‐hypofractionated treatment where small setup errors can lead to higher doses to organs at risk (OARs). Although bowel and bladder preparation protocols reduce inter‐fraction variability, inconsistent patient adherence still results in OAR variability.
Conor Sinclair Smith, Isabelle Gagne, Karl Otto, Carter Kolbeck, Joshua Giambattista, Abraham Alexander, Sonja Murchison, Andrew Pritchard, Erika Chin   +8 more
wiley   +1 more source

A Cost-Utility Analysis of Secondary Prophylaxis for Variceal Hemorrhage [PDF]

, 2004
Joel H. Rubenstein, Glenn M. Eisen, John M. Inadomi   +2 more
openalex   +1 more source